DEE GUY: Open Payments
NPI 1396150116 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,451 in 159 payments from 49 companies in 2025. Trend: 2023 $2,605 · 2024 $3,187 · 2025 $3,451
Food & beverage: $3,352Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $349 |
| Daiichi Sankyo Inc. | 12 | $267 |
| AstraZeneca Pharmaceuticals LP | 9 | $264 |
| PFIZER INC. | 11 | $188 |
| BeOne Medicines USA, Inc. | 11 | $167 |
| Janssen Biotech, Inc. | 9 | $163 |
| Incyte Corporation | 8 | $145 |
| ABBVIE INC. | 6 | $131 |
| Genentech USA, Inc. | 5 | $113 |
| PharmaEssentia USA Corporation | 5 | $111 |
Products named: Enhertu, KISQALI, BRUKINSA, BESREMI, JAKAFI, SARCLISA, IMFINZI, Venclexta.
Industry payments across AL — which companies pay providers there.
